What is the recommended starting dose and titration schedule for norepinephrine (noradrenaline) infusion in an adult with hypotension (mean arterial pressure < 65 mmHg) after adequate fluid resuscitation?

Norepinephrine Dosing in Hypotensive Adults

Start norepinephrine at 0.1–0.5 mcg/kg/min (approximately 8–12 mcg/min or 0.5 mg/h in a 70 kg adult) via continuous IV infusion, targeting a mean arterial pressure of 65 mmHg, after administering at least 30 mL/kg crystalloid bolus. 1, 2

Critical Pre-Administration Requirements

Before initiating norepinephrine, you must administer a minimum 30 mL/kg crystalloid bolus to avoid severe organ hypoperfusion from vasoconstriction in hypovolemic patients. 1, 3 This fluid resuscitation should occur before or simultaneously with vasopressor initiation—never delay norepinephrine if systolic blood pressure is below 70 mmHg, as prolonged hypotension independently increases mortality. 1, 4

• Use balanced crystalloids (lactated Ringer's or Plasma-Lyte) preferentially over normal saline for initial resuscitation. 1
• In severe, life-threatening hypotension (systolic <70 mmHg or diastolic ≤40 mmHg), start norepinephrine as an emergency measure while fluid resuscitation continues rather than waiting for complete volume repletion. 1, 4

Preparation and Concentration

The standard adult concentration is prepared by adding 4 mg norepinephrine to 250 mL D5W, yielding 16 mcg/mL. 1, 2

Administration Route

Central venous access is strongly preferred to minimize extravasation risk and tissue necrosis. 3, 1, 2 However, if central access is unavailable or delayed, peripheral IV or intraosseous administration can be used temporarily during initial resuscitation. 1

• Place an arterial catheter as soon as practical for continuous blood pressure monitoring. 1
• If extravasation occurs, immediately infiltrate 5–10 mg phentolamine diluted in 10–15 mL saline intradermally at the site to prevent tissue death. 1, 5

Target Blood Pressure

Target a mean arterial pressure (MAP) of 65 mmHg for most patients with septic shock. 3, 1, 2 This represents the minimum threshold for adequate organ perfusion based on strong guideline recommendations. 3

• Patients with chronic hypertension may require higher MAP targets (70–80 mmHg), while younger normotensive patients may tolerate lower pressures. 1
• Complement MAP targets with serial markers of tissue perfusion: lactate clearance, urine output >50 mL/h, mental status, capillary refill, and skin temperature. 3, 1

Titration Protocol

Monitor blood pressure and heart rate every 5–15 minutes during initial titration. 1, 2

• Increase dose by 0.5 mg/h every 4 hours as needed to achieve target MAP and adequate tissue perfusion. 1
• Typical maintenance dose ranges from 2–4 mcg/min, though requirements vary widely. 2
• The usual therapeutic range is 0.1–2 mcg/kg/min. 1

Escalation Strategy for Refractory Hypotension

When norepinephrine reaches 0.25 mcg/kg/min and hypotension persists despite adequate fluid resuscitation, add vasopressin 0.03–0.04 units/min as second-line therapy rather than continuing to escalate norepinephrine alone. 3, 1, 2 This approach is based on moderate-quality evidence showing vasopressin acts on different vascular receptors and may reduce norepinephrine requirements. 3

• Do not increase vasopressin above 0.03–0.04 units/min; reserve higher doses for salvage therapy only. 1
• Alternatively, add epinephrine 0.1–0.5 mcg/kg/min if vasopressin is unavailable. 1
• For persistent hypoperfusion with evidence of myocardial dysfunction despite adequate vasopressors, add dobutamine up to 20 mcg/kg/min to improve cardiac output. 3, 1
• Consider hydrocortisone 200 mg/day (continuous infusion or divided doses) for refractory shock requiring high-dose vasopressors. 1

Hemodynamic Effects

Norepinephrine rapidly increases MAP and stabilizes blood pressure more effectively than fluid resuscitation alone. 4 Early administration increases cardiac output through increased cardiac preload (by converting unstressed blood volume to stressed volume) and improved cardiac contractility. 6, 4 This effect occurs even in patients with poor baseline cardiac function (LVEF ≤45%), though benefits diminish when MAP exceeds 75 mmHg in this population. 6

• Norepinephrine typically causes no change or modest decrease in heart rate due to baroreceptor-mediated vagal reflex, despite β1-adrenergic stimulation. 5
• Urine output improves when adequate renal perfusion pressure is achieved, contrary to older concerns about renal vasoconstriction. 7, 8

Critical Pitfalls to Avoid

Never use dopamine as first-line therapy—it is associated with higher mortality and more arrhythmias compared to norepinephrine. 3, 1, 5 Dopamine should only be considered in highly selected patients with absolute bradycardia and low risk of tachyarrhythmias. 3, 5

Do not delay norepinephrine initiation in profound hypotension (diastolic ≤40 mmHg or diastolic shock index ≥3) while attempting to complete fluid resuscitation, as prolonged hypotension independently worsens outcomes. 4

Avoid inadequate volume resuscitation before starting norepinephrine, as vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure readings. 1

Do not use phenylephrine as first-line therapy—it may raise blood pressure while worsening tissue perfusion due to pure alpha-agonism without cardiac support. 1

Never mix norepinephrine with sodium bicarbonate or other alkaline solutions in the same IV line, as alkalinity inactivates catecholamines. 1

Special Populations

In pregnant patients with septic shock, start norepinephrine at 0.02 mcg/kg/min targeting MAP 65 mmHg, and consider more restrictive initial fluid boluses (1–2 L) due to lower colloid oncotic pressure and higher pulmonary edema risk. 1

In pediatric patients, start at 0.1 mcg/kg/min and titrate to desired clinical effect, with typical range 0.1–1.0 mcg/kg/min; maximum doses up to 5 mcg/kg/min may be necessary. 1

Evidence Quality

The recommendation for norepinephrine as first-choice vasopressor in septic shock carries strong recommendation with moderate-quality evidence from multiple international guidelines. 3, 1 Comparative studies demonstrate norepinephrine's superiority over dopamine, with one randomized trial showing 93% success rate with norepinephrine versus 31% with dopamine in reversing hyperdynamic septic shock. 7